Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's Disease.
Mov Disord
; 37(1): 196-200, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34612548
ABSTRACT
BACKGROUND:
Emerging evidence indicates that the apolipoprotein E (APOE) ε4 exacerbates α-synuclein pathology.OBJECTIVE:
To determine whether APOE ε4 contributes to motor progression in early Parkinson's disease (PD).METHODS:
Longitudinal data were obtained from 384 patients with PD divided into APOE ε4 carriers (n = 85) and noncarriers (n = 299) in the Parkinson's Progression Marker Initiative. Participants underwent yearly motor assessments over a mean follow-up period of 78.9 months. Repeated measures and linear mixed models were used to test the effects of APOE ε4.RESULTS:
The motor progression was significantly more rapid in patients with PD carrying APOE ε4 than in noncarriers (ß = 0.283, P = 0.026, 95% confidence interval 0.033-0.532). Through subgroup analysis, we found that the effect of APOE ε4 was significant only in patients with high amyloid ß burden (ß = 0.761, P < 0.001, 95% confidence interval 0.0356-1.167).CONCLUSIONS:
APOE ε4 may be associated with rapid motor progression in PD. © 2021 International Parkinson and Movement Disorder Society.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Apolipoprotein E4
Limits:
Humans
Language:
En
Journal:
Mov Disord
Journal subject:
NEUROLOGIA
Year:
2022
Type:
Article
Affiliation country:
China